Business Description
Latigo Biotherapeutics is a California-based pharmaceutical company focused on developing new pain treatments that work without the risk of addiction. The company is building a portfolio of drugs that block specific nerve signals responsible for transmitting pain, targeting both short-term conditions like acute pain and longer-term issues such as osteoarthritis. Founded in 2018 and headquartered in Thousand Oaks, the company has multiple drug candidates at various stages of development.
